US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

104.92

+2.922.86%

Volume:25.97K

Turnover:2.73M

Market Cap:131.15M

PE:- -

High:105.65

Open:104.03

Low:103.98

Close:102.00

52wk High:110.05

52wk Low:68.05

Shares:1.25M

Float Shares:1.25M

Volume Ratio:2.80

T/O Rate:2.08%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Hold interest rates despite inflation risk, Shadow MPC tells Bank of England

Barclays downgrades Scholar Rock on valuation after FDA approval

Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares

Prescient Therapeutics Extends Securities Purchase Plan Deadline

Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Cabaletta Bio Boosts Cash Through Warrant Exercises

Scholar Rock price target raised to $84 from $76 at BMO Capital

Bank of England predicted to raise interest rates this year

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Scholar Rock announces FDA approval of isembyld

Pharming wins FDA nod to extend Joenja use to younger APDS children

Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings

Bank of America Reveals 5.22% Indirect Stake in Qiagen

Revvity to acquire Human Cell Design

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BBP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":104.9185,"timestamp":1789675200000,"preClose":101.9998,"halted":0,"volume":25972,"delay":0,"changeRate":0.028614761989729405,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Pre-Mkt","change":2.9187,"latestTime":"09-18 04:44:05 EDT","open":104.03,"high":105.65,"low":103.975,"amount":2726893.0000400003,"amplitude":0.016422,"askPrice":166.82,"askSize":100,"bidPrice":90.53,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":104.9185,"sharesOutstanding":600004,"nav":102.17,"aum":127713134.29,"bidAskSpread":0.002459,"postHourTrading":{"tag":"盘后","latestPrice":108.32,"preClose":104.9185,"latestTime":"19:30 EDT","volume":160,"amount":17307.3895,"timestamp":1789687804652,"change":3.4015,"changeRate":0.03242,"amplitude":0.032406},"volumeRatio":2.8014237795198804,"impliedVol":0.2249,"impliedVolPercentile":0.436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.8014237795198804,"shares":1250004,"dividePrice":0,"high":105.65,"amplitude":0.016422,"preClose":101.9998,"low":103.975,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":104.9185,"eps":0,"divideRate":0,"volume":25972,"delay":0,"ttmEps":0,"open":104.03,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":103.4736,"twentyDayClose":109.9037,"sixtyDayClose":92.7358},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["NVIB","TECB","BMED","IBB","MRNX","MRNY","IDNA","BK4588","LABU","LFSC","PINK","BBP","GNMX","TBXU","GDOC","IYH","BK4585","SYNB","PSCH","XLVX","FRTY","RSPH","MEDI","IEIH","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667965642","title":"Hold interest rates despite inflation risk, Shadow MPC tells Bank of England","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965642","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667965642?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:37","pubTimestamp":1789472226,"startTime":"0","endTime":"0","summary":"City AM's Shadow MPC has called for interest rates to be held.  The Bank of England has been urged to hold interest rates even as inflation is set to peak higher than previously expected due to the continuation of the Iran war, City AM’s Shadow Monetary Policy Committee has said.The Bank should leave interest rates unchanged at 3.75 per cent, according to most top economists in the mirror organisation, although some warned the case for waiting on a hike is “thin”.City AM’s Shadow MPC was split 6-3 among those calling for no change in interest rates and those calling for monetary policy to be tightened.“The argument that policymakers need to look past “temporary shocks” is wearing increasingly thin,” he said.Anna Leach – Institute of Directors, chief economistVote: Raise 25 basis pointsLeach said her vote came down to a “close call”. Her decision was determined by inflation remaining above the two per cent target for two years, price expectations remaining elevated and business costs sq","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/09/bailey-boe-copy-7-e1789468241631.jpg?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/09/bailey-boe-copy-7-e1789468241631.jpg?w=286&h=161&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/hold-interest-rates-despite-inflation-risk-shadow-mpc-tells-bank-of-england/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/hold-interest-rates-despite-inflation-risk-shadow-mpc-tells-bank-of-england/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["HIDV","MDLV","BBEU","AVSD","ANEW","CAOS","CDC","DECU","MODL","ILCV","FLV","PSC","BBP","FT","TEQI","PRVS","SAMT","TSLP","FXR","DFUV","EES","KOMP","SDOG","RHTX","CGUS","ARP","IJK","VOTE","EQRR","BSR","REGL","IMCG","MAPP","IUS","DIVZ","VAW","UCC","BKDV","LGH","RULE","PEVC","ADPV","LCG","FXD","RMIF","CGDV","CLIX","BAMA","CGUI","FXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","SYNB","CDIG","TBXU","LABU","RSPH","GDOC","PINK","IDNA","FRTY","LFSC","GNMX","TSPA","PSCH","TECB","IYH","IBB","XLVX","IEIH","TACU","NVIB","BMED","MRNY","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661509","title":"Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661509","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661509?lang=en_us&edition=fundamental","pubTime":"2026-09-15 12:47","pubTimestamp":1789447668,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has issued an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, develops medical therap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-seeks-asx-quotation-for-21-9-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","FHLC","SYNB","XT","RSPH","BK4585","JDOC","FWD","AGNG","IEIH","LNGR","DARP","BK4588","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667316690","title":"Prescient Therapeutics Extends Securities Purchase Plan Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667316690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667316690?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:02","pubTimestamp":1789437732,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics Limited ( ($AU:PTX) ) just unveiled an update. Prescient Therapeutics Limited, an ASX-listed biotechnology company trading u...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-extends-securities-purchase-plan-deadline-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","IEIH","JDOC","RSPH","LENZ","FWD","IBB","BK4539","AGNG","BK4585","XT","DARP","BK4588","LNGR","FHLC","BK4139","BBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667694618","title":"Syntara Sets 2026 AGM Date as It Refocuses on Fibrosis and Cancer Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2667694618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667694618?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:16","pubTimestamp":1789431375,"startTime":"0","endTime":"0","summary":"Syntara Limited ( ($AU:SNT) ) has provided an update. Syntara Limited, an ASX-listed clinical-stage biotechnology company based in Sydney, develops...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/syntara-sets-2026-agm-date-as-it-refocuses-on-fibrosis-and-cancer-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","AGNG","BK4585","FHLC","XT","SYNB","JDOC","BK4588","FWD","IBB","IEIH","BBC","RSPH","BBP","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667869541","title":"Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2667869541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667869541?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:37","pubTimestamp":1789418272,"startTime":"0","endTime":"0","summary":"Niki BioSolutions Inc ( ($NIKI) ) just unveiled an announcement. Niki BioSolutions Inc operates in the biotechnology and molecular diagnostics sect...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","FWD","XT","GNMX","LNGR","JDOC","BBP","DARP","HELX","RSPH","SYNB","BK4588","IBB","IEIH","BMED","HTEC","FHLC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","XLVX","SYNB","IBB","IEIH","BMED","GNMX","RSPH","NVIB","BFRI","MRNX","IDNA","TECB","MRNY","LABU","TBXU","BBP","FRTY","GDOC","BK4585","IYH","MEDI","BK4007","BK4588","PINK","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","PSCH","BBP","BMED","RSPH","BK4585","IBB","SYNB","BK4588","IYH","LABU","TECB","NVIB","MRNY","FRTY","IDNA","LFSC","PINK","GDOC","MEDI","XLVX","TBXU","GNMX","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667666613","title":"Cabaletta Bio Boosts Cash Through Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2667666613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667666613?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:31","pubTimestamp":1789389071,"startTime":"0","endTime":"0","summary":"Cabaletta Bio ( ($CABA) ) has provided an update. Cabaletta Bio, a biotechnology company developing engineered immune cell therapies for autoimmune...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cabaletta-bio-boosts-cash-through-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","IEIH","LNGR","AGNG","IBB","BK4588","BK4139","BK4585","DARP","RSPH","CABA","XT","FHLC","JDOC","FWD","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BMED","GNMX","LABU","TECB","MRNX","IYH","BK4139","PINK","IBRN","IBB","RSPH","TBXU","THNR","LFSC","BK4588","MEDI","SRRK","IDNA","PSCH","BBP","FRTY","BK4585","GDOC","IEIH","NVIB","MRNY","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500316","title":"Bank of England predicted to raise interest rates this year","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500316","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667500316?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:00","pubTimestamp":1789383602,"startTime":"0","endTime":"0","summary":"The Bank of England could raise interest rates this year.  The Bank of England will raise interest rates to four per cent by the end of the year, a top Wall Street bank has warned.Goldman Sachs has upgraded its interest rate expectations amid concerns that inflation could jump higher than previously expected.The bank said an interest rate hike this year was more likely as it revised up its inflation forecast for the beginning of 2027 to 3.9 per cent. A previous forecast suggested inflation would peak at 3.3 per cent later this year.However, the bank’s forecasters held that rates would be kept at 3.75 per cent when the MPC meets this Thursday. As many as four Bank officials out of the nine-strong MPC could demand higher borrowing rates due to concerns over rising energy prices.Goldman Sachs economists James Moberly and Sven Jari Stehn said there was “some risk” that the MPC signals an upcoming tightening in monetary policy later this week.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/05/Bank-of-England-2-1200x800-2.jpeg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/05/Bank-of-England-2-1200x800-2.jpeg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bank-of-england-predicted-to-raise-interest-rates-this-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bank-of-england-predicted-to-raise-interest-rates-this-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["07366","RJZ","TSLW","BK4582","CGDV","FXR","TACN","TSLO","CLIX","TSLQ","ISVL","BK4588","BBP","CRSH","BBEU","ELOL","TSLL","IJK","09366","IDEV","TESC","VAW","TSYY","TSLG","TSLS","UCC","TLA","TSLR","FLGB","TESL","TSLY","PEVC","TSLZ","LRCY","BK4585","TSDD","TSLT","ANEW","07766","TSLI","09766","KOMP","TSLP","AVSD","CAOS","FXL","TSL","TEST","DFUV","TSII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","RSPH","IBB","SYNB","NVIB","IYH","MRNX","LFSC","BK4139","IDNA","BK4179","TBXU","IEIH","PINK","FRTY","TECB","TLX","MRNY","PSCH","BMED","BK4585","GDOC","BBP","MEDI","FET","GNMX","XLVX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","TBXU","NVIB","RSPH","TECB","BK4588","SYNB","THNR","BK4139","IEIH","BMED","BK4585","IBB","SRRK","GNMX","MRNY","PINK","GDOC","LFSC","PSCH","IDNA","LABU","IYH","FRTY","BBP","IBRN","XLVX","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","TECB","BK4588","GDOC","IDNA","BBP","BK4585","NVIB","GNMX","BMED","TBXU","LFSC","MRNX","RSPH","LABU","PINK","SYNB","MRNY","PSCH","IBB","IEIH","IYH","MEDI","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517941","title":"Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517941","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517941?lang=en_us&edition=fundamental","pubTime":"2026-09-11 09:44","pubTimestamp":1789091072,"startTime":"0","endTime":"0","summary":"The latest update is out from Nextbiomedical Co. Ltd. ( ($KR:389650) ). Nextbiomedical Co. Ltd., a biotechnology company, is strengthening its pres...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nextbiomedical-targets-global-investors-at-2026-kis-biotech-day?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nextbiomedical-targets-global-investors-at-2026-kis-biotech-day?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","BBP","ISBC","FHLC","XT","IBB","BK4585","IEIH","SYNB","BK4211","BK4588","LNGR","RSPH","DARP","JDOC","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666446516","title":"GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666446516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666446516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:02","pubTimestamp":1789074144,"startTime":"0","endTime":"0","summary":"The latest update is out from GeoVax Labs ( ($GOVX) ). GeoVax Labs, Inc., a clinical-stage biotechnology firm listed on Nasdaq as GOVX, develops va...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","BBC","FHLC","FWD","LCLG","RSPH","SYNB","AGNG","NQmain","JDOC","LU2065732104.USD","BK4588","XT","BK4585","IBB","BK4097","IEIH","BBP","DARP","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559053","title":"Cheap Biologic Drug Alternatives Stall, Threatening U.S. Healthcare Savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559053","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559053?lang=en_us&edition=fundamental","pubTime":"2026-09-11 01:51","pubTimestamp":1789062660,"startTime":"0","endTime":"0","summary":"Ninety percent of the expensive, widely used biologic drugs facing patent expiration by 2034 have no lower-cost alternatives in development, according to a new report by the Association for Accessible","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BBP","IHE","BK4585","XLV","BK4137","BK4588","XBI","HCSG","LU0128526141.USD","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530163","title":"Bank of America Reveals 5.22% Indirect Stake in Qiagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530163?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:37","pubTimestamp":1788986261,"startTime":"0","endTime":"0","summary":"Qiagen ( ($QGEN) ) has issued an update. QIAGEN N.V., a Netherlands-based life sciences and biotechnology group focused on molecular diagnostics an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1718418525.SGD","LU1804176565.USD","FTXO","LU0256863902.USD","LU0648000940.SGD","BK4581","LU0256863811.USD","BK4582","DARP","LU0314106906.USD","LU0648001328.SGD","LU1366192091.USD","LU1280957306.USD","IE00BKVL7J92.USD","FWD","XT","HELX","UYG","IYG","BBP","IEIH","TFNS","IE00B1BXHZ80.USD","LU0070302665.USD","LU0130517989.USD","JDOC","RSPH","IE00B19Z3581.USD","FHLC","BMED","BAC","LU1496350502.SGD","SYNB","LU2129689431.USD","XLF","PGF","IBB","IYF","LU1894683264.USD","FNCL","KBWB","LU0208291251.USD","VFH","LU2133065610.SGD","AGNG","HTEC","BK4534","GNMX","LU0321505868.SGD","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458412","title":"Revvity to acquire Human Cell Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458412","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458412?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:05","pubTimestamp":1788948328,"startTime":"0","endTime":"0","summary":"Revvity (RVTY) announced it has entered into a definitive agreement to acquire Human Cell Design, or HCD, a France-based biotechnology company spec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revvity-to-acquire-human-cell-design-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN0W2T93.GBP","FHLC","SYNB","LNGR","BK4121","JDOC","BBP","IE00BLDYK493.USD","AGNG","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IEIH","IBB","DARP","RVTY","BK4588","BK4585","FWD","IE00B64QTZ34.USD","RSPH","XT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":185,"code":"91000000","status":"200"}]}}